Viewing Study NCT06870006


Ignite Creation Date: 2025-12-26 @ 1:18 PM
Ignite Modification Date: 2026-01-01 @ 6:22 AM
Study NCT ID: NCT06870006
Status: RECRUITING
Last Update Posted: 2025-03-11
First Post: 2025-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population
Sponsor: Meyer Children's Hospital IRCCS
Organization:

Study Overview

Official Title: Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population
Status: RECRUITING
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Electrocardiogram (ECG) Q-T prolongation is a cardiac electrophysiological disorder associated with the occurrence of arrhythmias potentially fatal. Several psychotropic drugs are associated with an increased risk of QT prolongation, which is why in clinical practice a baseline ECG is performed before a psychotropic drug is prescribed. However, there are no validated protocols establishing when to repeat this examination or describing clinical events when this examination should be repeated in clinical follow-up.

The study aims to investigate the incidence of QTc prolongation events as a side effect of chronic psychotropic drug administration. For this purpose, ECGs will be recorded and confounding factors of patients at the beginning of psychotropic therapy and after 3, 6 and 12 months will be analyzed.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: